peach Diagnose Engrave substance p inhibitor playground Martyr Darts
Substance P and pain chronicity | Cell and Tissue Research
Substance P Exacerbates Dopaminergic Neurodegeneration through Neurokinin-1 Receptor-Independent Activation of Microglial NADPH Oxidase | Journal of Neuroscience
Intrathecally administered substance P activated the spinal defecation center and enhanced colorectal motility in anesthetized rats | American Journal of Physiology-Gastrointestinal and Liver Physiology
Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus* - Ständer - 2019 - British Journal of Dermatology - Wiley Online Library
Selective G protein signaling driven by substance P–neurokinin receptor dynamics | Nature Chemical Biology
Substance P Inhibitor Promotes Tendon Healing in a Collagenase-Induced Rat Model of Tendinopathy - Kyung Rae Ko, Soo-Hong Han, Sujin Choi, Hyun-Ju An, Eun-Bee Kwak, Yunhui Jeong, Minjung Baek, Jusung Lee, Junwon
Combining incretin-based drugs and RAAS inhibitors: more cons than pros? - The Lancet Diabetes & Endocrinology
Frontiers | The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders
Involvement of substance P and the NK-1 receptor in cancer progression - ScienceDirect
Substance P (Neurokinin P) | Neurotransmitter | MedChemExpress
The emerging role of substance P/neurokinin-1 receptor signaling pathways in growth and development of tumor cells | SpringerLink
Clinical Applications of Substance P (Neurokinin-1 Receptor) Antagonist in Canine Medicine
Scheme of biological functions of substance P. Once the nerve ending... | Download Scientific Diagram
THE BRAIN FROM TOP TO BOTTOM
SP-SAP: How It's Different From Substance P Antagonists – Advanced Targeting Systems